BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 7813597)

  • 1. Immune intervention in type I diabetes mellitus--current clinical and experimental approaches.
    Kolb H
    Exp Clin Endocrinol; 1994; 102(4):269-72. PubMed ID: 7813597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Immunoprevention of Type I diabetes mellitus].
    Spinas GA
    Ther Umsch; 1996 Dec; 53(12):882-8. PubMed ID: 9036566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Principles of immunotherapy in insulin-dependent diabetes mellitus].
    Bretzel RG
    Wien Klin Wochenschr; 1988 Jun; 100(13):435-42. PubMed ID: 3043913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New prospects for immunotherapy at diagnosis of type 1 diabetes.
    Pozzilli P; Leslie RD
    Diabetes Metab Res Rev; 2009 May; 25(4):299-301. PubMed ID: 19405079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genes and engineered cells as drugs for type I and type II diabetes mellitus therapy and prevention.
    Giannoukakis N; Pietropaolo M; Trucco M
    Curr Opin Investig Drugs; 2002 May; 3(5):735-51. PubMed ID: 12090547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Innovative immune-based therapeutic approaches for the treatment of type 1 diabetes mellitus.
    Eldor R; Cohen IR; Raz I
    Int Rev Immunol; 2005; 24(5-6):327-39. PubMed ID: 16318985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular mechanisms of death ligand-mediated immune modulation: a gene therapy model to prolong islet survival in type 1 diabetes.
    Sanlioglu AD; Griffith TS; Omer A; Dirice E; Sari R; Altunbas HA; Balci MK; Sanlioglu S
    J Cell Biochem; 2008 Jun; 104(3):710-20. PubMed ID: 18247339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunological disorders of type 1 diabetes mellitus.
    Ziegler M; Ziegler B
    Exp Clin Endocrinol; 1989 Sep; 94(1-2):97-114. PubMed ID: 2689194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sertoli cell-induced reversal of adult rat pancreatic islet beta-cells into fetal-like status: potential implications for islet transplantation in type I diabetes mellitus.
    Luca G; Calvitti M; Neri LM; Becchetti E; Capitani S; Basta G; Angeletti G; Fanelli C; Brunetti P; Calafiore R
    J Investig Med; 2000 Nov; 48(6):441-8. PubMed ID: 11094867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Immunointervention in type 1 diabetes mellitus].
    Vialettes B
    Diabete Metab; 1992; 18(1):3-10; discussion 11-3. PubMed ID: 1563533
    [No Abstract]   [Full Text] [Related]  

  • 11. [Immune modulation therapy in type I diabetes mellitus].
    Schmeidl R; Teuber J; Paschke R; Schwedes U; Usadel KH
    Fortschr Med; 1986 Dec; 104(45):879-83. PubMed ID: 3542769
    [No Abstract]   [Full Text] [Related]  

  • 12. Autoimmune disorders in diabetes.
    Boitard C; Debray-Sachs M; Bach JF
    Adv Nephrol Necker Hosp; 1986; 15():281-305. PubMed ID: 3082114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of immunotherapy in type I diabetes mellitus.
    Geffner ME; Lippe BM
    West J Med; 1987 Mar; 146(3):337-43. PubMed ID: 3554759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progress in the immunointervention of type-1 diabetes mellitus.
    Schernthaner G
    Horm Metab Res; 1995 Dec; 27(12):547-54. PubMed ID: 8750784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Routes to regenerating islet cells: stem cells and other biological therapies for type 1 diabetes.
    Kodama S; Faustman DL
    Pediatr Diabetes; 2004; 5 Suppl 2():38-44. PubMed ID: 15601373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasmacytoid dendritic cells in autoimmune diabetes - potential tools for immunotherapy.
    Nikolic T; Welzen-Coppens JM; Leenen PJ; Drexhage HA; Versnel MA
    Immunobiology; 2009; 214(9-10):791-9. PubMed ID: 19628297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tackling type 1 diabetes: new immune-modulating drugs attack the root cause.
    Shekhar C
    Chem Biol; 2007 Dec; 14(12):1305-6. PubMed ID: 18096495
    [No Abstract]   [Full Text] [Related]  

  • 18. Islet replacement vs. regeneration: hope or hype?
    Ramiya V; Schatz D
    Pediatr Diabetes; 2004; 5 Suppl 2():45-56. PubMed ID: 15601374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outlook for immune intervention in type I diabetes.
    Grob PJ
    Curr Probl Clin Biochem; 1983; 12():119-40. PubMed ID: 6360542
    [No Abstract]   [Full Text] [Related]  

  • 20. Insulin-specific tolerance in diabetes.
    Gottlieb PA; Eisenbarth GS
    Clin Immunol; 2002 Jan; 102(1):2-11. PubMed ID: 11781061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.